Anito-cel moves closer to potential approval as Maryland-founded biotech becomes cornerstone asset in cell therapy expansion
In a defining move for the cell therapy sector,...
Pennsylvania’s life sciences ecosystem is sprinting ahead.
On February 18, 2026, Governor Josh Shapiro and state officials announced that global healthcare leader Johnson & Johnson...
AstraZeneca’s decision to acquire the remaining China rights to AbelZeta’s GPC3-targeting armored CAR-T therapy is not just a deal tidy-up. It’s a strategic consolidation...
New solutions are emerging to address a growing exposure as advanced therapies continue to scale
The procedure was scheduled, the team was ready, and the...
Philadelphia, PA – October 14, 2025 — Cabaletta Bio (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing engineered T cell therapies for patients...
The Association for the Advancement of Blood & Biotherapies (AABB) has released its first edition of Cell and Gene Therapy Standards for Pharmacy, a...
